Search Results - "SPALDING, William"

Refine Results
  1. 1

    Concomitant Use of Psychotropic Medication With Stimulants for the Treatment of ADHD in Children and Adolescents: A Retrospective Insurance Claims Study in the United States by Zhou, Zhou, Betts, Keith A., Bocharova, Iryna, Kinrich, David, Spalding, William M.

    Published in Journal of attention disorders (01-01-2020)
    “…Objective: To evaluate annual concomitant psychotropic medication use among stimulant-treated children/adolescents with ADHD. Method: Children/adolescents with…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Treatment characteristics among patients with binge-eating disorder: an electronic health records analysis by Spalding, William M., Bertoia, Monica L., Bulik, Cynthia M., Seeger, John D.

    Published in Postgraduate medicine (03-04-2023)
    “…Treatment for adults diagnosed with binge-eating disorder (BED) includes psychotherapy and/or pharmacotherapy and aims to reduce the frequency of binge-eating…”
    Get full text
    Journal Article
  4. 4

    Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population by Doshi, Jalpa A, Cai, Qian, Buono, Jessica L, Spalding, William M, Sarocco, Phil, Tan, Hiangkiat, Stephenson, Judith J, Carson, Robyn T

    “…The prevalence of irritable bowel syndrome with constipation (IBS-C) is estimated to be between 4.3% and 5.2% among adults in the United States. Little is…”
    Get full text
    Journal Article
  5. 5

    Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation by Cuffari, Carmen, Spalding, William, Achenbach, Heinrich, Thakur, Manoj, Gabriel, André

    “…A previous phase 3 trial of prucalopride in pediatric patients (6 months–18 years old) with functional constipation (FC) demonstrated no efficacy versus…”
    Get full text
    Journal Article
  6. 6

    Suicidality risk among adults with binge‐eating disorder by Bulik, Cynthia M., Bertoia, Monica L., Lu, Mei, Seeger, John D., Spalding, William M.

    Published in Suicide & life-threatening behavior (01-10-2021)
    “…Objective To estimate relative suicidality risk associated with binge‐eating disorder (BED). Methods Retrospective study of patients identified as having BED…”
    Get full text
    Journal Article
  7. 7

    A case-control comparison of direct healthcare-provider medical costs of chronic idiopathic constipation and irritable bowel syndrome with constipation in a community-based cohort by Herrick, Linda M, Spalding, William M, Saito, Yuri A, Moriarty, James, Schleck, Cathy

    Published in Journal of medical economics (04-03-2017)
    “…Patients with constipation account for 3.1 million US physician visits a year, but care costs for patients with irritable bowel syndrome with constipation…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Predictors of Pancreatitis Among Patients with Inflammatory Bowel Disease Treated with Vedolizumab: Observation from a Large Global Safety Database by Wernicke, Joe F., Verstak, Tatsiana, Zhang, Tianming, Spalding, William, Lee, Laurie, Cheng, Yue, Ademi, Alicia

    Published in Drugs -- real world outcomes (01-12-2023)
    “…Background Patients with inflammatory bowel diseases (IBDs) are at increased risk of pancreatitis. Data from a global safety database (GSD) were queried to…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population by Cai, Qian, Buono, Jessica L, Spalding, William M, Sarocco, Phil, Tan, Hiangkiat, Stephenson, Judith J, Carson, Robyn T, Doshi, Jalpa A

    Published in Journal of medical economics (01-02-2014)
    “…To evaluate total annual all-cause, gastrointestinal-related, and symptom-related healthcare costs among chronic constipation (CC) patients and estimate…”
    Get more information
    Journal Article
  13. 13

    Thromboembolic cardiovascular risk among arthritis patients using cyclooxygenase-2-selective inhibitor or nonselective cyclooxygenase inhibitor nonsteroidal anti-inflammatory drugs by Spalding, William M, Reeves, Mathew J, Whelton, Andrew

    Published in American journal of therapeutics (01-01-2007)
    “…Selective cyclooxygenase (COX)-2 inhibitors have been associated with an increased risk of thromboembolic cardiovascular (CV) events. Prior studies have found…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Epidemiology of status epilepticus in the United States: A systematic review by Lu, Mei, Faure, Mareva, Bergamasco, Aurore, Spalding, William, Benitez, Arturo, Moride, Yola, Fournier, Martha

    Published in Epilepsy & behavior (01-11-2020)
    “…Convulsive status epilepticus (CSE) is a life-threatening neurologic emergency, which is defined by the International League Against Epilepsy (ILAE) as…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Efficacy of Prucalopride for Chronic Idiopathic Constipation: An Analysis of Participants With Moderate to Very Severe Abdominal Bloating by Staller, Kyle, Hinson, Jimmy, Kerstens, René, Spalding, William, Lembo, Anthony

    Published in The American journal of gastroenterology (01-01-2022)
    “…This post hoc analysis evaluated the effect of prucalopride on abdominal bloating in participants with chronic idiopathic constipation (CIC) who had moderate…”
    Get full text
    Journal Article
  19. 19

    A Review of the Cardiovascular Safety of Prucalopride in Patients With Chronic Idiopathic Constipation by Tack, Jan, Derakhchan, Katayoun, Gabriel, André, Spalding, William, Terreri, Brian, Youssef, Ashraf, Kreidieh, Bahij, Kowey, Peter R., Boules, Mena

    Published in The American journal of gastroenterology (08-05-2023)
    “…Prokinetic agents, specifically 5-hydroxytryptamine type 4 (5-HT 4 ) receptor agonists, have been shown to provide relief in chronic idiopathic constipation…”
    Get full text
    Journal Article
  20. 20

    QT-Interval Prolongation, Torsades de Pointes, and Heart Failure With EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: Systematic Review by Khokhar, Bilal, Chiang, Beatrice, Iglay, Kristy, Reynolds, Kamika, Rodriguez-Ormaza, Nidia, Spalding, William, Freedland, Eric

    Published in Clinical lung cancer (01-06-2024)
    “…•The reported incidence of cardiac toxicity with EGFR TKI therapy for NSCLC varies.•Monitoring patients receiving EGFR TKI therapy for QTp, TdP, and HF is…”
    Get full text
    Journal Article